Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01778439 |
Title | A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | OncoMed Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Francisco/Helen Diller Cancer Institute | San Francisco | California | 94115 | United States | Details | |
University of Colorado Denver -RCI-South Tower | Aurora | Colorado | 80045 | United States | Details | |
Karmanos Cancer Institute (KCI) | Detroit | Michigan | 48201 | United States | Details | |
Wayne State University/Oncology Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details |